Rare diseases
Investigational molecules
Locations
Level 3, 5 West Victoria Dock Road, 1 River Crescent, DD2 1UJ, United Kingdom
Exscientia AI Limited is involved in clinical research for advanced solid tumors, with interest in oncology settings where treatment options are limited and disease control remains challenging.
The sponsor’s research in this area reflects a focus on therapies intended for patients with advanced malignancies across multiple tumor types.
Exscientia AI Limited runs clinical trials in conditions such as Adenocarcinoma pancreas, Breast cancer, Squamous cell carcinoma of head and neck, Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
